Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-11

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for atorvastatin calcium from Aurobindo Pharma Limited, confirming approval of a generic atorvastatin calcium product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)